Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aditya Sarawgi

Is Bio-Techne Corporation Stock Underperforming the S&P 500?

Valued at a market cap of $9.3 billion, Bio-Techne Corporation (TECH) is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. Based in Minneapolis, Minnesota, the company operates through Protein Sciences and Diagnostics & Genomics segments.

Companies worth between $2 billion to $10 billion are generally classified as “mid-cap stocks," and Bio-Techne fits this criterion perfectly. The company aids in drug discovery efforts and provides the means for accurate clinical tests and diagnoses with thousands of products in its portfolio.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.